Symed Labs Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 9.30 M
as on 15-11-2024
- Company Age 26 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 253.60 Cr
as on 15-11-2024
- Satisfied Charges ₹ 171.04 Cr
as on 15-11-2024
- Revenue 28.76%
(FY 2023)
- Profit 30.76%
(FY 2023)
- Ebitda 82.05%
(FY 2023)
- Net Worth 6.18%
(FY 2023)
- Total Assets 17.74%
(FY 2023)
About Symed Labs
The Corporate was formerly known as Symed Labs Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 9.30 M.
The company currently has active open charges totaling ₹253.60 Cr. The company has closed loans amounting to ₹171.04 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Symed Labs Limited India is Hari Bodepudi as CEO. Kamal Sharma, Hari Bodepudi, Vijayalakshmi, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24231TG1998PLC029961
- Company No.
029961
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Aug 1998
- Date of AGM
22 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Symed Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hari Bodepudi | CEO | 07-Jul-2021 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamal Sharma  | Director | 01-Dec-2022 | Current |
| Hari Bodepudi | Director | 07-Jul-2021 | Current |
| Vijayalakshmi | Nominee Director | 07-Jul-2021 | Current |
| Srinivas Vasireddy | Director | 28-Jun-2023 | Current |
| Kalidindi Raju | Director | 07-Jul-2021 | Current |
| Pradip Kanakia | Director | 04-Mar-2022 | Current |
Financial Performance and Corporate Structure Insights of Symed Labs.
Symed Labs Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.76% increase. The company also saw a substantial improvement in profitability, with a 30.76% increase in profit. The company's net worth moved up by a moderate rise of 6.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Symed Labs?
In 2022, Symed Labs had a promoter holding of 26.00% and a public holding of 74.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vindhya Pharma (India) Private LimitedActive 18 years 4 monthsHari Bodepudi, Srinivas Vasireddy and 1 more are mutual person
- Vandana Life Sciences Private LimitedActive 22 years 2 days
Srinivas Vasireddy and Kalidindi Raju are mutual person
- S.V. Labs Private LimitedActive 21 years 3 months
Srinivas Vasireddy and Kalidindi Raju are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Sep 2023 | ₹25.00 Cr | Open |
Others Creation Date: 25 Sep 2023 | ₹36.00 Cr | Open |
Others Creation Date: 25 Sep 2023 | ₹14.00 Cr | Open |
How Many Employees Work at Symed Labs?
Symed Labs has a workforce of 949 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Symed Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Symed Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
